Form 10 Explorer
10-K
Annual Report
ACRO BIOMEDICAL CO., LTD.

CIK: 1622996

File #: 000-55643

Period End: Dec 31, 2025

Fiscal Year: 2025

View on EDGAR
Balance Sheet
28 line items · 2 periods
XBRL
ItemDec 31, 2025Dec 31, 2024
Balance Sheets
ASSETS
Current Assets
Cash
4,098476
Other Non-Operating Current Assets
10,0000
Other Non-Operating Current Assets
04,600
Lease Agreement - Hong Kong
2,285
Total Current Assets
14,0985,076
Operating Lease Right-of-Use Asset
026,898
TOTAL ASSETS
14,09831,974
LIABILITIES AND STOCKHOLDERS' DEFICIT
Current Liabilities
Accounts Payable
55,550154,460
Other Current Liabilities
20,00020,000
Due to related parties
325,512125,588
Operating Lease Liability, Current
026,898
Total Current and Total Liabilities
401,062326,946
Stockholders' Deficit
Preferred Stock
00
Total Stockholders' Equity
60,04260,042
Total Stockholders' Equity
32,311,93532,302,781
Total Stockholders' Equity
(32,758,941)(32,657,795)
Total Stockholders' Deficit
(386,964)(294,972)
Accumulated Deficit
(32,758,941)(32,657,795)
Additional Paid-In Capital
32,311,93532,302,781
Common Stock
60,04260,042
Preferred Stock
00
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT
14,09831,974
ACRO BIOMEDICAL CO., LTD. — 10-K Filing | Form 10 Explorer